FWD Group Holdings (01828) Report Interpretation

Overview

This pre-1H26-results update revises Goldman Sachs' forecasts for FWD Group Holdings. The institution expects slower sales recovery in Thailand and FX pressure, but sees margins, new-business CSM and lower costs supporting materially higher earnings forecasts and retains Buy.

Core views

Goldman Sachs updates its estimates ahead of FWD's 1H26 results, scheduled for 26 August, to reflect recent sales momentum, bond issuance, a proposed perpetual-bond redemption and market developments. It lowers FY26-28E annualized premium equivalent (APE) sales by 3-4%, attributing the change to a more gradual Thailand recovery and FX headwinds, particularly US-dollar appreciation against the Japanese yen. The revised APE forecasts are US$2.563bn for FY26E, US$2.813bn for FY27E and US$3.098bn for FY28E, versus prior forecasts of US$2.645bn, US$2.924bn and US$3.235bn. The report leaves VNB broadly unchanged because it raises the VNB-margin assumption by about 1 percentage point, consistent with margin expansion in 1Q26. Revised VNB forecasts are US$1.045bn, US$1.146bn and US$1.264bn for FY26E-28E, representing 10% annual growth in each forecast year; VNB margins are forecast at 40.8%, 40.7% and 40.8%. For 1H26E, Goldman Sachs expects VNB of US$554mn, up 10% year on year and 2% above consensus, with Hong Kong and Japan expected to grow while Thailand VNB is expected to decline 7% year on year. Goldman Sachs raises FY26 new-business CSM by 4%, following 18% year-on-year growth in 1Q26 that it sees as running ahead of VNB growth. Its FY26-28E new-business CSM forecasts rise to US$1.642bn, US$1.819bn and US$2.005bn, 4%, 3% and 2% above prior estimates. The report also fine-tunes OPAT forecasts to US$589mn, US$671mn and US$772mn, modestly above earlier estimates. The most substantial revision is to net profit: FY26-28E NPAT forecasts increase 42%, 24% and 24% to US$267mn, US$321mn and US$407mn. Goldman Sachs attributes the large percentage increases mainly to operating-expense and financing-cost savings, alongside a low starting base. For 1H26E, it forecasts OPAT attributable to shareholders of US$292mn, up 16% year on year and 3% above consensus, and NPAT of US$138mn, versus US$10mn in 1H25 and 39% above consensus. Ahead of results, the institution expects investors to focus on whether regulatory scrutiny of broker-channel sales practices could disrupt Hong Kong VNB growth, whether Thailand sales and VNB growth recover in 2H26, and the scale of operating and investment variances in embedded value. Goldman Sachs maintains Buy and sets a 12-month price target of HK$42, down from HK$43, using a 0.8x FY27E P/EV multiple. Its target-multiple calculation is based on ROEV minus long-term growth divided by cost of equity minus growth, with a 1.9% long-term growth assumption.

Analysis framework

Goldman Sachs refreshes operating forecasts using recent sales, margin, financing and market developments, then translates them into APE, VNB, CSM, OPAT and net-profit estimates. It values FWD on a forward price-to-embedded-value basis, setting the target multiple from expected return on embedded value, cost of equity and a 1.9% long-term growth assumption.

Methodology notes

• Valuation methodsP/EV insurance valuation

  Forward price-to-embedded-value valuation using a target multiple derived from ROEV, cost of equity and long-term growth.

  The report applies 0.8x FY27E P/EV to derive its HK$42 target price. Its stated formula links the justified multiple to expected return on embedded value, the cost of equity and a 1.9% perpetual growth assumption.

• Financial-sector metricsEmbedded Value (EV) and New Business Value (NBV)

  Insurance value creation is assessed through VNB, VNB margin, new-business CSM, embedded value and free-surplus measures.

  These measures let the report distinguish changes in sales from changes in profitability and capital generation; a higher VNB-margin assumption offsets the lower APE-sales outlook in its revised forecasts.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• FWD Group Holdings (1828.HK)

  Primary covered insurer; the report maintains Buy ahead of 1H26 results.

  Strengths

  VNB is expected to grow 10% year on year in 1H26E, while improved VNB margin and faster new-business CSM growth support the value outlook.

  Weaknesses

  FY26-28E APE sales estimates are reduced by 3-4% due to slower Thailand recovery and FX headwinds.

  Comparison

  1H26E VNB of US$554mn is forecast 2% above consensus; 1H26E OPAT of US$292mn is forecast 3% above consensus.

  Risks

  Regulatory scrutiny of Hong Kong broker-channel practices, Thailand recovery, financing costs, capital and liquidity constraints, and Southeast Asian market volatility.

Key data

• 1H26E VNBUS$554mnExpected to rise 10% year on year and be 2% above consensus.
• FY26-28E APE revision-3% to -4%Reduced for a slower Thailand recovery and FX headwinds.
• FY26-28E NPAT revision+42%, +24%, +24%Raised to US$267mn, US$321mn and US$407mn, mainly from operating-expense and financing-cost savings.
• FY26E new-business CSMUS$1.642bnRaised 4% following 18% year-on-year growth in 1Q26.
• Target price and valuationHK$42; 0.8x FY27E P/EV12-month target price, reduced from HK$43.
• Price and implied upsideHK$30.00; 40.0%Price as of 31 July 2026 close and stated upside to the target price.

Impact & implications

The report argues that weaker sales assumptions do not materially alter its VNB outlook because margin expansion supports value creation. Lower operating and financing costs drive the larger earnings upgrade, while Hong Kong regulatory developments, Thailand's second-half recovery and embedded-value variances remain the principal near-term result catalysts.

Risks

• A short operating track record and adverse experience development could weaken performance.
• Debt-financing costs, capital-framework changes, capital-flow restrictions in stressed markets and liquidity constraints could pressure value.
• Intangible-asset impairments, volatile Southeast Asian growth and competitive pressure could reduce results.
• Execution risk remains in transitioning toward higher-margin products.
• Uncertainty in PRC laws and regulations is a stated downside risk.

What to watch

• Potential disruption to Hong Kong VNB growth from regulatory focus on broker-channel sales practices.
• Thailand sales and VNB-growth recovery in 2H26.
• Embedded-value operating and investment variances in the 1H26 results.